This Is What Whales Are Betting On Elevance Health
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bearish stance on Elevance Health (NYSE:ELV), with 81% of the spotted trades being bearish. The whale has been targeting a price range from $430.0 to $480.0 for Elevance Health over the last 3 months. The current price of ELV is $439.31, up 0.5%. Truist Securities maintains a Buy rating on Elevance Health with a price target of $560.
June 29, 2023 | 6:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A whale investor has taken a bearish stance on Elevance Health, which may put downward pressure on the stock in the short term. However, Truist Securities maintains a Buy rating with a price target of $560, indicating potential upside.
The bearish stance taken by a whale investor, who typically has significant influence on the market, could put downward pressure on Elevance Health's stock price in the short term. However, the maintained Buy rating and $560 price target from Truist Securities suggest potential upside, which could counteract some of this bearish pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100